NASDAQ:IDXG

Interpace Diagnostics Group Stock News

etoro logo Buy IDXG
*Your capital is at risk
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
Interpace Biosciences (IDXG) announced today that its subsidiary, Interpace Diagnostics, has entered into a contract with Avalon Healthcare Solutions (Avalon), a specialty benefit management company w
all Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arch Coal, Glacier Bancorp and IHS Markit on Monday. HIGHLIGHTS * Arch
Interpace Diagnostics Group (NASDAQ:IDXG)‘s stock had its “buy” rating restated by stock analysts at Maxim Group in a note issued to investors on Friday, AnalystRatings.com reports. They current
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx (CDNA) today and set a price target of $43.00. The company's shares closed last Thursday
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx ( CDNA – Research Report ) today and set a price target of $43.00 . The company’s shares closed last Thursday at $24.08. According
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.11%
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Interpace Diagnostics Group (IDXG) and Principia Biopharma
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunomedics (IMMU), Interpace Diagnostics Group (IDXG) and
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunomedics ( IMMU – Research Report ), Interpace Diagnostics Group ( IDXG – Research Report ) and
Gainers Dynavax (NASDAQ: DVAX) shares are trading higher after the company reported collaboration with Valneva to advance vaccine development for coronavirus. Sleep Number (...
Acquired Biopharma Business of Cancer Genetics in Second Half of 2019 Through Q1-2020 Raised $47 million from Two Top Private Equity FirmsProvides First Quarter 2020 Range of.
Some blood tests being marketed to tell people if they have had the new coronavirus are a "disaster", Roche Chief Executive Severin Schwan said on Wednesday as he prepares to launch the drugmaker's ow
Interpace (IDXG) announced today that it will release its financial results for the fourth quarter and full year 2019 this afternoon. Company management will host a conference call and webcast to dis
La croissance a été alimentée par la principale division Pharmaceuticals, dont les revenus ont progressé de 3% à 12,26 milliards. L'action a clôturé en nette hausse.
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rockwell Med (RMTI) and Motus Gi Holdings (MOTS) with
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE